Earnings Estimates Moving Higher for Exelixis (EXEL): Time to Buy?

Exelixis (EXEL) is exhibiting positive momentum as analysts have revised earnings estimates upward, leading to a Zacks Rank #2 (Buy); the consensus EPS estimate for the current quarter has increased 15.39% over the last 30 days, and the full-year estimate has risen 12.9% to $2.57 per share, representing a 28.5% increase year-over-year. This positive revision trend has already driven the stock up 15.2% in the past four weeks, with analysts suggesting further upside potential remains.

Analysis

Exelixis (EXEL) is exhibiting a significant positive shift in analyst sentiment, underscored by robust upward revisions to its earnings estimates and a consequent Zacks Rank #2 (Buy). Specifically, the consensus earnings per share (EPS) estimate for the current quarter has risen by 15.39% over the past 30 days to $0.62, with four analysts revising estimates higher versus one lower; however, this $0.62 figure still represents a 26.19% decrease compared to the year-ago reported earnings. In contrast, the full-year outlook is markedly stronger: the consensus EPS estimate stands at $2.57, indicating a substantial 28.5% year-over-year growth. This full-year estimate has increased by 12.9% over the past month, supported by nine upward revisions and no downward revisions from covering analysts. This positive revision trend, which Zacks' research indicates has a strong correlation with near-term stock price movements, has already contributed to a 15.2% increase in EXEL's stock price over the past four weeks, suggesting that the improving earnings outlook is being recognized by the market.

Key Decisions for Investors

• Given the strong upward trend in earnings estimate revisions, particularly for the full year, and the Zacks Rank #2 (Buy) designation, investors might consider Exelixis as a potential addition to their growth-oriented portfolios.
• Despite the stock's recent 15.2% appreciation, the improving full-year earnings forecast, projecting a 28.5% year-over-year EPS increase, could support further upside potential.
• Investors should carefully monitor the upcoming current-quarter earnings release, paying attention to how the market reconciles the anticipated year-over-year EPS decline of 26.19% with the positive revisions to that quarter's estimate and the robust full-year growth expectations.